Cedars Sinai Intellectual Property Co 4
4 · Prometheus Biosciences, Inc. · Filed Mar 8, 2023
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-03-08$114.59/sh−865,000$99,120,350→ 4,001,132 total(indirect: See Footnote)
Footnotes (1)
- [F1]The securities reported herein are held of record by Cedars Sinai Intellectual Property Company, which is a wholly owned subsidiary of Cedars-Sinai Medical Center.